We have studied the biological effects of two structural analogs of cytokinins, 3-methyl-7-(pentylamino)pyrazolo(4,3-d)pyimiine and 3-methyl-7-(benzylamino)pyrazolo(4,3d)pyrimidine, on tobacco cell suspension cultures. These two cytokinin analogs are highly inhibitory to cytokinin-autonomous and cytokinin-requiring tobacco cells. The growth inhibitory effect is markedly antagonized by benzyladenine, but not by adenine.
Several substituted 3-methylpyrazolo(4,3-d)pyrimidine analogs of cytokinins have been reported to be highly potent inhibitors of the cytokinin-dependent growth of cytokinin-requiring tobacco callus tissues. On the basis that the growth inhibition observed at a given combination of analog and cytokinin concentrations was abolished or reduced in presence of higher concentrations of cytokinins, these analogs were described as cytokinin antagonists (1) . The first to be described was 3-methyl-7-(3-methylbutylamino)pyrazolo (4,3-d) pyrimidine (1) and the most potent in a series of 7-substituted 3-methylpyrazolo(4,3-d)pyrimidines described later by Skoog et al. (7) , was 3-methyl-7-(pentylamino)pyrazolo(4,3-d)pyrimidine (I). Indeed, in the presence of 0.003 LM N6-(A2-isopentenyl)adenine, it was lethal at a concentration of 0.2 jAM and antagonist activity was detected at the minimal concentration of 0.03 lsm in the tobacco callus bioassay system (7) .
Development of specific cytokinin antagonists, defined as structural analogs of cytokinins which compete with cytokinins in cytokinin-dependent biological systems (2) , is of considerable potential value in studies ofthe mechanism ofaction ofcytokinins. First, one experimental approach of the mechanism(s) of action of cytokinins is the identification and cellular localization of cytokinin "receptors" (6) . Structural analogs of cytokinins which exhibit anticytokinin activity should be useful to assess binding activity. Second, by rendering them cytokinin-dependent if the action of the anticytokinins were reversible, the anticytokinins would extend the study of cytokinin action to biological systems which normally do not require an exogenous cytokinin. Third, there is still no certain answer to the central question: is metabolic "activation" a prerequisite for the expression of the biological activity of cyto-1 Supported by NATO kinins such as BA or zeatin, or are they the functional molecular species? The cytokinin antagonists, by decreasing the efficiency of cytokinins in a biological system the response of which is limited by the concentration of the supplied cytokinin, should help to assess the significance of the various cytokinin metabolites which are formed if the metabolism of the supplied cytokinin(s) were modified by the cytokinin antagonists.
However, it has not been established that cytokinin antagonists act through the same metabolic pathway(s) or at the same cellular receptor site(s) as do cytokinins, and the cellular level at which they interact is also unknown. Our concern with cytokinin utilization and activity in tobacco cells grown as cell suspensions in liquid medium which are suitable, in contrast to tobacco callus tissue grown on solid medium, for study of the reciprocal interaction of cytokinins and anticytokinins at the level of their respective uptake and metabolism, led us to investigate the biological effects of two substituted 3-methylpyrazolo(4,3-d)pyrimidines on tobacco cell suspension cultures. We chose 3-methyl-7-(pentylamino)pyrazolo(4,3-d)pyrimidine (I) as a reference compound since it was the most potent anticytokinin in the series described by Skoog et al. (7) , and 3-methyl-7-(benzylamino)pyrazolo(4,3-d)-pyrimidine (II) since we could expect to obtain it radiolabeled.
We describe herein the biological effects of these two cytokinin structural analogs on cytokinin-requiring and cytokinin-autonomous tobacco cells grown as cell suspensions in liquid medium. Both analogs appear to be very potent inhibitors of the growth of these tobacco cell suspensions and this inhibitory effect is markedly antagonized by BA.
MATERIALS AND METHODS

CYTOKININ ANALOGS
3-methyl-7-(pentylamino)pyrazolo(4,3-d)pyrimidine (I) and 3-methyl-7-(benzylamino)pyrazolo(4,3-d)pyrimidine (II) were synthesized from 3-methyl-7-(methylthiopyrazolo(4,3-d)pyrimidine and the appropriate amine as described by Hecht et al. (1) and Skoog et al. (7) . Purity of these cytokinin analogs was assessed by Sephadex LH20 chromatography and GLC. Their identities were established by MS. Furthermore, our sample of 3-methyl-7-(pentylamino)pyrazolo(4,3-d) pyrimidine exhibited the UV spectral characteristics described by Skoog et al. (7) . Details will be reported elsewhere. (5) as 100-ml cultures in 800-ml round-bottomed flasks placed on a rotary shaker (60 rpm) in a growth chamber at 26 C under white light (2,000 lux at the level of the flasks). Cells of cell line 13 were grown in medium containing 0.75 AM 2,4-D and 40 mM sucrose. Cells from the cytokininrequiring cell line were grown in medium containing 0.2 pM 2,4-D, 0.060 ,UM BA, and sucrose at the growth-limiting concentration of 20 mM. These cells require a cytokinin for cell division in the sense that addition of a cytokinin to the culture medium is absolutely necessary for indefinite growth through repeated subcultures. However, suspensions of cytokinin-requiring cells initiated at high cell densities by directly diluting 15-ml aliquots of stock cell suspensions in 100 ml of cytokinin-less fresh medium would grow during one to two passages (between three and five doublings). This apparent cytokinin-independent growth of cytokinin-requiring cells of cell line 19-3 is referred in this study as "carryovei" growth. Such residual growth was minimized to about one doubling of the initial cell suspension density when cells used as inoculum were washed according to the protocol described below.
BIOASSAY PROCEDURES
Cytokinin activity or growth inhibition activity was assayed with 10-ml suspension cultures grown in test tubes (20-mm diameter, 220-mm length) agitated on roller tubes (60 rpm) placed in a growth chamber at 26 C, under diffuse light.
The test compounds and BA were dissolved in ethanol at a concentration of 10 mm. These solutions were freshly diluted with distilled H20 in order to obtain 50 iAM stock solutions whose concentrations were systematically checked by measurement of UV absorption with a Cary 15 spectrophotometer. Suitable serial dilutions were prepared from these stock solutions to obtain the required quantities of test compounds or (and) BA in solution in 1 ml of distilled H20 in the test tubes which were then autoclaved (8 min, 120 C). This procedure presumably removed the trace amount of ethanol brought with the test compounds and which anyhow was shown to be without any effect on the growth of control cell suspensions when present at the maximal concentration of 0.05% (v/v).
The test tubes were then aseptically inoculated with 9 ml of the appropriate freshly subcultured cell suspension with a laboratorymodified glass volumetric dispenser.
Cytokinin-independent Growth of Suspensions of Tobacco Cells of Cell Line 13. Fractions of 300 ml of fresh medium containing the concentrations of 2,4-D and sucrose specified above were inoculated with 33 ml of a 14-day-old stock cell suspension culture.
This dilution yielded an initial wet packed cell volume of 0.35 ml/10 ml of cell suspension. Carryover Growth of Suspensions of Cytokinin-requiring Tobacco Cells. Fractions of 300 ml of fresh cytokinin-free medium (0.2 tIM 2,4-D and 40 mM sucrose) were inoculated with 45 ml of a 14-day-old cell suspension culture. This yielded an initial wet packed cell volume of 0.30 ml/10 ml of cell suspension.
Cytokini-dependent Growth of Suspensions of Cytokinin-requiring Tobacco Cells. Cells of a 14-day-old 100-ml stock cell suspension culture were collected under sterile conditions on a 30-,um mesh nylon filter, rinsed with 100 ml of cytokinin and auxinfree fresh medium (basal medium), and resuspended in 300 ml of fresh basal medium. This cell suspension was then agitated for I h at 26 C. Cells were then collected on a filter as above, resuspended in 100 ml of basal medium, and 30-ml aliquots of this washed-cell suspension were used to inoculate 300-ml fractions of fresh cytokinin-free medium (0.2 pM 2,4-D and 40 mM sucrose).
After 9 days, cell suspensions were transferred into 12-ml graduated conical centrifuge tubes and centrifuged for autonomous tobacco cells in about the same concentration range as I. Both analogs equally inhibited the carryover growth of cytokinin-requiring cells in cytokinin-free culture medium. The concentrations of analog which produced 50%o or near 100o growth inhibition (respectively, 150 and Iloo) were found to be highly reproducible from one experiment to another and therefore these parameters were chosen for the purpose of comparing the respective biological activities of I and II which are summarized in Table I .
Effect of BA on the Growth-inhibitory Effect of Cytokinin Analogs. As shown in Figure 2 , inhibition of carryover growth of Table I Benzylamino, iiM (Table II) , but apparently to a lesser extent than in the case of cell suspension cultures of cytokinin-requiring cells (Fig. 2) . Adenine at the concentration of 100 um had no effect on the growth inhibitory effect of II (Table II) , indicating thereby that the cytokinin-analog antagonism is specific. BA at the concentration of 0.1 LM was a better antagonist of the benzylamino analog than of the pentylamino analog. To obtain the same level of growth inhibition in the presence of BA than in its absence, only twice as much of I was necessary whereas in the case of II, six times as much was required (Table II) (Fig. 3) .
Cytotoxic Effect and Growth-inhibitory Effect of the Analogs. In bioassays, inhibition of cell suspension cultures of normally green cells was accompanied by browning. Observation under the microscope revealed that most of the cells were dead. Therefore, the cytotoxicity of these analogs was investigated. As shown in Table III , cytokinin-autonomous tobacco cells died rapidly when cultured in the presence of growth-inhibitory concentrations of I. However, cell death occurred significantly later in suspension cultures containing 0.03 ,IM I than in suspension cultures containing 0.1 ULM I. Similarly, death of most cells was observed when cytokinin-requiring tobacco cell suspensions were subcultured in the presence of growth-inhibitory concentrations of either I or II. It is evident that growth inhibition of tobacco cell suspensions by I or II resulted from the death of the cells. weeks without any detectable cell division activity. Cells in stationary phase cultures appeared to be insensitive to the addition of I or II in the culture medium even at concentrations up to 5 pUM (Table IV) results -differ in some instances at some differences in activity which may be due to cell line differences in sensitivity or/and to culture conditions. Two differences deserve to be emphasized. First 
